{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["homeobox A9", "microRNA-182", "osteosarcoma", "wingless-type/\u03b2-catenin signaling pathway"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29254169", "DateRevised": {"Year": "2022", "Month": "09", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "09", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.18632/oncotarget.21167"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "8", "Issue": "60", "PubDate": {"Year": "2017", "Month": "Nov", "Day": "24"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "MicroRNA-182 downregulates Wnt/\u03b2-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.", "Pagination": {"StartPage": "101345", "EndPage": "101361", "MedlinePgn": "101345-101361"}, "Abstract": {"AbstractText": ["We investigated the mechanisms by which microRNA (miR)-182 promotes apoptosis and inhibits proliferation in human osteosarcoma (OS) cells. Levels of miR-182 and Homeobox A9 (HOXA9) expression were compared between human OS and normal cells. Subjects were divided into OS and normal groups. We analyzed the target relationship of miR-182 and Homeobox A9 (HOXA9). Cells were then assigned into blank, negative control, miR-182 mimics, miR-182 inhibitors, siRNA-HOXA9, or and miR-182 inhibitors + siRNA-HOXA9 groups. Cell function was assayed by CCK-8, flow cytometry and wound healing assay. Additionally, we analyzed OS tumor growth in a xenograft mouse model. Dual-luciferase reporter assays indicated miR-182 directly targets HOXA9. Reverse transcription quantitative PCR and western blotting revealed elevated expression of miR-182, WIF-1, BIM, and Bax, and reduced expression of HOXA9, Wnt, \u03b2-catenin, Survivin, Cyclin D1, c-Myc, Mcl-1, Bcl-xL, and Snail in osteosarcoma cells treated with miR-182 mimic or siRNA-HOXA9 as compared to controls. Osteosarcoma cells also exhibited decreased cell proliferation, migration, and tumor growth, and increased apoptosis when treated with miR-182 mimic or siRNA-HOXA9. Correspondingly, in a xenograft mouse model, osteosarcoma tumor volume and growth were increased when cells were treated with miR-182 inhibitor and decreased by miR-182 mimic or siRNA-HOXA9. These results indicate that miR-182 downregulates Wnt/\u03b2-catenin signaling, inhibits cell proliferation, and promotes apoptosis in osteosarcoma cells by suppressing HOXA9 expression."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China."}], "LastName": "Zhang", "ForeName": "Zi-Feng", "Initials": "ZF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China."}], "LastName": "Wang", "ForeName": "Yong-Jian", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China."}], "LastName": "Fan", "ForeName": "Shao-Hua", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedics, The Third Affiliated Hospital, Shenzhen University, Shenzhen 518002, P.R. China."}], "LastName": "Du", "ForeName": "Shi-Xin", "Initials": "SX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopedics, The Third Affiliated Hospital, Shenzhen University, Shenzhen 518002, P.R. China."}], "LastName": "Li", "ForeName": "Xue-Dong", "Initials": "XD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China."}], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China."}], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, P.R. China."}], "LastName": "Zheng", "ForeName": "Yuan-Lin", "Initials": "YL"}], "PublicationTypeList": ["Journal Article", "Retracted Publication"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "CommentsCorrectionsList": [{"RefSource": "Oncotarget. 2022 Sep 06;13:1003. doi: 10.18632/oncotarget.28269", "PMID": "36082358"}], "CoiStatement": "CONFLICTS OF INTEREST The authors declare that there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Uluckan O, Bakiri L, Wagner EF. Characterization of mouse model-derived osteosarcoma (OS) cells in vitro and in vivo. Methods Mol Biol. 2015:297\u2013305. 1267.", "ArticleIdList": ["25636475"]}, {"Citation": "Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3\u201313.", "ArticleIdList": ["20213383"]}, {"Citation": "Seong BK, Lau J, Adderley T, Kee L, Chaukos D, Pienkowska M, Malkin D, Thorner P, Irwin MS. SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization. Oncogene. 2015;34:3582\u201392.", "ArticleIdList": ["25220418"]}, {"Citation": "Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, Serra M, Burger H, Cleton-Jansen AM, Myklebost O. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 2012;7:e48086.", "ArticleIdList": ["PMC3485010", "23133552"]}, {"Citation": "Cai Y, Mohseny AB, Karperien M, Hogendoorn PC, Zhou G, Cleton-Jansen AM. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol. 2010;220:24\u201333.", "ArticleIdList": ["19882675"]}, {"Citation": "Chiang CH, Hou MF, Hung WC. Up-regulation of miR-182 by beta-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim Biophys Acta. 2013:3067\u201376. 1830.", "ArticleIdList": ["23333633"]}, {"Citation": "Hu J, Lv G, Zhou S, Zhou Y, Nie B, Duan H, Zhang Y, Yuan X. The downregulation of MiR-182 is associated with the growth and invasion of osteosarcoma cells through the regulation of TIAM1 expression. PLoS One. 2015;10:e0121175.", "ArticleIdList": ["PMC4431740", "25973950"]}, {"Citation": "Stewart DJ. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst. 2014;106:djt356.", "ArticleIdList": ["24309006"]}, {"Citation": "Umbreit C, Aderhold C, Faber A, Sommer JU, Sauter A, Hofheinz RD, Stern-Strater J, Hoermann K, Schultz JD. Unexpected alteration of beta-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. Anticancer Res. 2013;33:2457\u201365.", "ArticleIdList": ["23749896"]}, {"Citation": "Park GB, Kim DJ, Kim YS, Lee HK, Kim CW, Hur DY. Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and beta-catenin expression and increases susceptibility to chemotherapeutic agents. Int J Oncol. 2015;46:185\u201394.", "ArticleIdList": ["25339127"]}, {"Citation": "Greer ER, Chao AT, Bejsovec A. Pebble/ECT2 RhoGEF negatively regulates the Wingless/Wnt signaling pathway. Development. 2013;140:4937\u201346.", "ArticleIdList": ["PMC3848189", "24198276"]}, {"Citation": "Chartier C, Raval J, Axelrod F, Bond C, Cain J, Dee-Hoskins C, Ma S, Fischer MM, Shah J, Wei J, Ji M, Lam A, Stroud M, et al. Therapeutic targeting of tumor-derived R-spondin attenuates beta-catenin signaling and tumorigenesis in multiple cancer types. Cancer Res. 2016;76:713\u201323.", "ArticleIdList": ["26719531"]}, {"Citation": "de Sousa EMF, Vermeulen L. Wnt signaling in cancer stem cell biology. Cancers (Basel) 2016:8.", "ArticleIdList": ["PMC4963802", "27355964"]}, {"Citation": "Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11\u201326.", "ArticleIdList": ["23258168"]}, {"Citation": "Yao L, Sun B, Zhao X, Zhao X, Gu Q, Dong X, Zheng Y, Sun J, Cheng R, Qi H, An J. Overexpression of Wnt5a promotes angiogenesis in NSCLC. Biomed Res Int. 2014:832562. 2014.", "ArticleIdList": ["PMC4066942", "24999479"]}, {"Citation": "Bikkavilli RK, Avasarala S, Van Scoyk M, Arcaroli J, Brzezinski C, Zhang W, Edwards MG, Rathinam MK, Zhou T, Tauler J, Borowicz S, Lussier YA, Parr BA, et al. Wnt7a is a novel inducer of beta-catenin-independent tumor-suppressive cellular senescence in lung cancer. Oncogene. 2015;34:5317\u201328.", "ArticleIdList": ["PMC4558401", "25728679"]}, {"Citation": "Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, Reis RM, Costello JF. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res. 2010;70:453\u201362.", "ArticleIdList": ["PMC2849935", "20068170"]}, {"Citation": "Collins CT, Hess JL. Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets. Oncogene. 2016;35:1090\u20138.", "ArticleIdList": ["PMC4666810", "26028034"]}, {"Citation": "Collins C, Wang J, Miao H, Bronstein J, Nawer H, Xu T, Figueroa M, Muntean AG, Hess JL. C/EBPalpha is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis. Proc Natl Acad Sci U S A. 2014;111:9899\u2013904.", "ArticleIdList": ["PMC4103350", "24958854"]}, {"Citation": "Brumatti G, Salmanidis M, Kok CH, Bilardi RA, Sandow JJ, Silke N, Mason K, Visser J, Jabbour AM, Glaser SP, Okamoto T, Bouillet P, D\u2019Andrea RJ, et al.  HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia. Oncotarget. 2013;4:1933\u201347.  https://doi.org/10.18632/oncotarget.1306.", "ArticleIdList": ["10.18632/oncotarget.1306", "PMC3875760", "24177192"]}, {"Citation": "Donaldson IJ, Amin S, Hensman JJ, Kutejova E, Rattray M, Lawrence N, Hayes A, Ward CM, Bobola N. Genome-wide occupancy links Hoxa2 to Wnt-beta-catenin signaling in mouse embryonic development. Nucleic Acids Res. 2012;40:3990\u20134001.", "ArticleIdList": ["PMC3351182", "22223247"]}, {"Citation": "Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D. HMGB1 promotes drug resistance in osteosarcoma. Cancer Res. 2012;72:230\u20138.", "ArticleIdList": ["22102692"]}, {"Citation": "McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi X, Hoang BH. The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Rev Anticancer Ther. 2011;11:1223\u201332.", "ArticleIdList": ["21916576"]}, {"Citation": "Leow PC, Tian Q, Ong ZY, Yang Z, Ee PL. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/beta-catenin antagonists against human osteosarcoma cells. Invest New Drugs. 2010;28:766\u201382.", "ArticleIdList": ["19730790"]}, {"Citation": "Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, Volinia S, Stein GS, Croce CM, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res. 2012;72:1865\u201377.", "ArticleIdList": ["PMC3328547", "22350417"]}, {"Citation": "Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin Oncol. 2011;38:724\u201333.", "ArticleIdList": ["22082758"]}, {"Citation": "Qiu Y, Luo X, Kan T, Zhang Y, Yu W, Wei Y, Shen N, Yi B, Jiang X. TGF-beta upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1. Mol Biosyst. 2014;10:679\u201385.", "ArticleIdList": ["24445397"]}, {"Citation": "Sun Y, Fang R, Li C, Li L, Li F, Ye X, Chen H. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun. 2010;396:501\u20137.", "ArticleIdList": ["20420807"]}, {"Citation": "Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X, Tang H. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J. 2012;279:1252\u201360.", "ArticleIdList": ["22325466"]}, {"Citation": "Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010;10:361\u201371.", "ArticleIdList": ["20357775"]}, {"Citation": "Sitwala KV, Dandekar MN, Hess JL. HOX proteins and leukemia. Int J Clin Exp Pathol. 2008;1:461\u201374.", "ArticleIdList": ["PMC2480589", "18787682"]}, {"Citation": "Eklund E. The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis. Crit Rev Oncog. 2011;16:65\u201376.", "ArticleIdList": ["PMC3243967", "22150308"]}, {"Citation": "Lewis TA, Sykes DB, Law JM, Munoz B, Rustiguel JK, Nonato MC, Scadden DT, Schreiber SL. Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia. ACS Med Chem Lett. 2016;7:1112\u20137.", "ArticleIdList": ["PMC5150668", "27994748"]}, {"Citation": "Zeisig BB, Kulasekararaj AG, Mufti GJ, So CW. SnapShot: Acute myeloid leukemia. Cancer Cell. 2012;22:698\u2013e1.", "ArticleIdList": ["23153541"]}, {"Citation": "Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. BID. BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science. 2010;330:1390\u20133.", "ArticleIdList": ["PMC3163443", "21127253"]}, {"Citation": "Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P, Strasser A, Kluck RM, Adams JM, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 2007;315:856\u20139.", "ArticleIdList": ["17289999"]}, {"Citation": "Gheysarzadeh A, Yazdanparast R. STAT5 reactivation by catechin modulates H2O 2-induced apoptosis through miR-182/FOXO1 pathway in SK-N-MC cells. Cell Biochem Biophys. 2015;71:649\u201356.", "ArticleIdList": ["25231457"]}, {"Citation": "Niquet J, Wasterlain CG. Bim, Bad, and Bax: a deadly combination in epileptic seizures. J Clin Invest. 2004;113:960\u20132.", "ArticleIdList": ["PMC379331", "15057301"]}, {"Citation": "Kouri FM, Hurley LA, Daniel WL, Day ES, Hua Y, Hao L, Peng CY, Merkel TJ, Queisser MA, Ritner C, Zhang H, James CD, Sznajder JI, et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev. 2015;29:732\u201345.", "ArticleIdList": ["PMC4387715", "25838542"]}, {"Citation": "Yeh CT, Yao CJ, Yan JL, Chuang SE, Lee LM, Chen CM, Yeh CF, Li CH, Lai GM. Apoptotic Cell Death and Inhibition of Wnt/beta-Catenin Signaling Pathway in Human Colon Cancer Cells by an Active Fraction (HS7) from Taiwanofungus camphoratus. Evid Based Complement Alternat Med. 2011:750230. 2011.", "ArticleIdList": ["PMC3057579", "21423639"]}, {"Citation": "Phromnoi K, Prasad S, Gupta SC, Kannappan R, Reuter S, Limtrakul P, Aggarwal BB. Dihydroxypentamethoxyflavone down-regulates constitutive and inducible signal transducers and activators of transcription-3 through the induction of tyrosine phosphatase SHP-1. Mol Pharmacol. 2011;80:889\u201399.", "ArticleIdList": ["PMC3198920", "21816954"]}, {"Citation": "Yan D, Dong XD, Chen X, Yao S, Wang L, Wang J, Wang C, Hu DN, Qu J, Tu L. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS One. 2012;7:e40967.", "ArticleIdList": ["PMC3407171", "22848417"]}, {"Citation": "Kohno H, Amatya VJ, Takeshima Y, Kushitani K, Hattori N, Kohno N, Inai K. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma. Oncol Rep. 2010;24:423\u201331.", "ArticleIdList": ["20596629"]}, {"Citation": "Gokhale A, Kunder R, Goel A, Sarin R, Moiyadi A, Shenoy A, Mamidipally C, Noronha S, Kannan S, Shirsat NV. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther. 2010;6:521\u20139.", "ArticleIdList": ["21358093"]}, {"Citation": "Tan M, Wu J, Cai Y. Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer. Biochem Biophys Res Commun. 2013;438:673\u20139.", "ArticleIdList": ["23939044"]}, {"Citation": "Dunleavy EM, Almouzni G, Karpen GH. H3.3 is deposited at centromeres in S phase as a placeholder for newly assembled CENP-A in G(1) phase. Nucleus. 2011;2:146\u201357.", "ArticleIdList": ["PMC3127096", "21738837"]}, {"Citation": "Coronado D, Godet M, Bourillot PY, Tapponnier Y, Bernat A, Petit M, Afanassieff M, Markossian S, Malashicheva A, Iacone R, Anastassiadis K, Savatier P. A short G1 phase is an intrinsic determinant of naive embryonic stem cell pluripotency. Stem Cell Res. 2013;10:118\u201331.", "ArticleIdList": ["23178806"]}, {"Citation": "Ou D, Wu Y, Liu J, Lao X, Zhang S, Liao G. miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin. Oncol Lett. 2016;12:2531\u20137.", "ArticleIdList": ["PMC5038158", "27698823"]}, {"Citation": "Song YM, Lian CH, Wu CS, Ji AF, Xiang JJ, Wang XY. Effects of bone marrow-derived mesenchymal stem cells transplanted via the portal vein or tail vein on liver injury in rats with liver cirrhosis. Exp Ther Med. 2015;9:1292\u20138.", "ArticleIdList": ["PMC4353761", "25780424"]}, {"Citation": "Ayuk SM, Abrahamse H, Houreld NN. The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. J Photochem Photobiol B. 2016;161:368\u201374.", "ArticleIdList": ["27295416"]}]}], "History": [{"Year": "2017", "Month": "4", "Day": "14"}, {"Year": "2017", "Month": "9", "Day": "4"}, {"Year": "2017", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2017", "Month": "11", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["29254169", "PMC5731879", "10.18632/oncotarget.21167", "21167"]}}]}